Nuveen Asset Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 130,308 shares of ZNTL stock, worth $532,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares

130,308

Previous 130,308 -0.0%

Holding current value

$532,959

Previous $1.97 Million 4.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$9.84 - $20.13 $21,037 - $43,037	2,138 Added 1.67%	130,308 $1.97 Million
Q3 2023 Nov 14, 2023	BUY	$19.63 - $28.29 $211,493 - $304,796	10,774 Added 9.18%	128,170 $2.57 Million
Q2 2023 Aug 14, 2023	BUY	$17.41 - $30.05 $50,227 - $86,694	2,885 Added 2.52%	117,396 $3.31 Million
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $25,162 - $38,881	-1,559 Reduced 1.34%	114,511 $1.97 Million
Q4 2022 Feb 14, 2023	SELL	$18.07 - $25.6 $135,452 - $191,897	-7,496 Reduced 6.07%	116,070 $2.34 Million

Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $227,364 - $356,613	11,239 Added 10.01%	123,566 $2.68 Million
Q2 2022 Aug 15, 2022	SELL	$17.91 - $52.25 $107,370 - $313,238	-5,995 Reduced 5.07%	112,327 $3.16 Million
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $97,047 - $188,797	-2,334 Reduced 1.93%	118,322 $5.79 Million
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $560,990 - $710,794	-8,383 Reduced 6.5%	120,656 $8.6 Million
Q3 2021 Nov 12, 2021	SELL	$46.83 - $73.5 $354,034 - $555,660	-7,560 Reduced 5.53%	129,039 $9.07 Million
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $736,939 - $1.23 Million	19,699 Added 16.85%	136,599 $7.27 Million
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $389,306 - $575,069	10,908 Added 10.29%	116,900 $5.07 Million
Q4 2020 Feb 16, 2021	BUY	$31.71 - $57.97 $2.07 Million - $3.79 Million	65,359 Added 160.85%	105,992 $5.51 Million
Q3 2020 Nov 16, 2020	BUY	$27.03 - $47.97 $4,568 - $8,106	169 Added 0.42%	40,633 $1.33 Million
Q2 2020 Aug 14, 2020	BUY	$23.2 - $54.8 $938,764 - $2.22 Million	40,464 New	40,464 $1.94 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

76.3M

Call Options Held

68.2K

Put Options Held

2.3K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $233M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Zentalis Pharmaceuticals, Inc. Transaction History